| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Kymera Therapeutics, Inc. (KYMR) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 49 sells. KYMR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 7.96M | $719.45M | - | |
| Dir | 2.22M | $200.74M | - | |
| Dir | 685.4K | $61.98M | - | |
| CEO | 666.2K | $60.24M | - | |
| CFO | 306.6K | $27.73M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 15, 2024 | Booth Bruce70 | Director | Sell | 127,543 | $40.25 | $5,133,263.14 | -0.4% | -14.1% | -15.3% | |
| Mar 13, 2024 | Booth Bruce70 | Director | Sell | 353,357 | $42.20 | $14,912,376.40 | -1.0% | -18.3% | -20.9% | |
| Mar 13, 2024 | Atlas Venture Fund X, L.P.69 | 10% Owner | Sell | 353,357 | $42.20 | $14,912,376.40 | -1.0% | -18.3% | -20.9% | |
| Mar 4, 2024 | Jacobs Bruce N.74 | Chief Financial Officer | Sell | 3,934 | $41.86 | $164,664.20 | -0.9% | -25.9% | -28.0% | |
| Mar 4, 2024 | Gollob Jared70 | Chief Medical Officer | Sell | 3,344 | $41.86 | $139,967.47 | -1.1% | -25.9% | -28.0% | |
| Feb 27, 2024 | Gollob Jared70 | Chief Medical Officer | Sale+OE | 400 | $45.00 | $18,000.00 | -0.5% | -23.0% | -18.8% | |
| Feb 21, 2024 | Albers Jeffrey W.65 | Director | Sale+OE | 5,000 | $39.05 | $195,257.67 | -100% | -8.7% | -3.2% | |
| Feb 9, 2024 | Gollob Jared70 | Chief Medical Officer | Sale+OE | 46,137 | $35.50 | $1,638,071.49 | -22.7% | +3.8% | +0.3% | |
| Jan 23, 2024 | Albers Jeffrey W.65 | Director | Sale+OE | 10,000 | $30.05 | $300,470.00 | -100% | +9.8% | +41.1% | |
| Jan 4, 2024 | Chiniara Ellen | Chief Legal Officer | Sell | 3,295 | $22.58 | $74,415.60 | -8.8% | +36.4% | +52.8% |